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 ABSTRACT 
 
Aim: To compare nurse prescribers and non-prescribers managing people with diabetes in English 
general practice regarding: a) characteristics of patients,  b) activities and processes of care, c)  
patient outcomes (self-management, clinical indicators, satisfaction), d) resource implications and 
costs 
Background: Over 35,000 nurses in United Kingdom are able to prescribe the same medicines as 
doctors provided that it is within their level of experience and competence. Over 30% of them, 
mostly in general practice, prescribe medicines for patients with diabetes.  
Design: A comparative case study.  
Method: Nurses managing care of people with diabetes were recruited in twelve general practices in 
England; six had prescribing capability, six did not. Patients, recruited by nurses, were followed for 
six months (2011-2012). 
Results: The patient sample comprised 131 in nurse prescriber sites, 83 in non-prescriber sites.  
Patients of prescribers had been diagnosed, and cared for by the nurse longer than those of non-
prescribers. There were no differences in reported self-care activities or HbA1c test results, between 
the patients of the two types of nurse; the mean HbA1c decreased significantly in both groups. 
Patients of prescribers were more satisfied. Consultations frequency was similar, but duration was 
longer for prescribers (by average of 7.7 minutes). Non-prescribing nurses sought support from 
other healthcare professionals more frequently. Most prescribing nurses were on a higher grade/ 
salary band than non-prescribers.  
Conclusion: Clinical outcomes of patients managed by prescribing and non-prescribing diabetes 
nurses are similar. Prescribing nurses had longer relationships with their patients, and longer 
consultations, possibly contributing to higher satisfaction with their care. Employment costs of 
prescribing nurses are likely to be higher.  
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SUMMARY STATEMENT 
 
Why this research is needed: 
 Care for people with diabetes is increasingly managed within general practice in the United 
Kingdom 
 Non-medical prescribing is a successful policy initiative and over 35,000 nurses are able to 
prescribe the same medicines as doctors (provided that it is within their level of experience and 
competence), of whom one third are in general practice and prescribe medicines for people with 
diabetes 
 Little is known about the value added of nurse prescribers, compared to nurses without 
prescribing capability, in the care of people with diabetes in general practice in England 
 
Key findings: 
 Management of people with diabetes in general practice by a nurse with prescribing capability, 
compared to a non prescribing nurse, may not affect self-care or HbA1c outcomes 
 Longer consultations of nurse prescribers may enable extra information exchange and advice-
giving, and result in higher patient satisfaction 
 Nurse prescribers managing people with diabetes work more independently than non-prescribing 
nurses but their additional qualifications may incur higher employment costs for the practice 
 
Implications for practice and research: 
 Careful planning of task shifting between professionals according to competencies is needed 
within general practice 
 More research is needed on the effects of nurse prescribing for people with diabetes from the 
patient perspective 
INTRODUCTION 
Over the past decade, the United Kingdom (UK) government has introduced plans for more flexible 
and innovative ways of working in the National Health Service (NHS) in order to deliver healthcare 
improvements (Department of Health (DoH) 2000). This modernisation process has involved the 
development and enhancement of the roles of healthcare professionals (DoH, 1999), an important 
part of which has been the introduction of prescribing capability for a range of health professionals. 
Non-medical Prescribing (NMP) was primarily introduced as a means to increase service efficiency 
and medicines access (DoH, 2006a). Nurse prescribing has also been introduced in a number of other 
countries including Australia, Canada, New Zealand, Sweden, Netherlands, Spain, and the US (Ball et 
al 2009), although in contrast to the UK, nurse prescribing in these countries addresses physician 
shortage and the unmet medicines needs of patients in remote areas (Kroezen et al 2011). 
 
There are approximately 38,000 NMPs (nurses, pharmacists, allied health professionals) in the UK 
and over 35,000 of these nurses (DoH, 2014).are able to prescribe the same medicines as doctors 
provided that it is within their level of experience and competence (Nursing and Midwifery Council 
(NMC) 2006). The majority are working at an advanced or specialist level (Courtenay & Carey 2008a, 
Courtenay et al 2012). NMP is a successful policy initiative, enabling faster medicines access, flexible, 
patient-centred care, service efficiency gains (Stenner et al, 2010, Courtenay et al, 2009a, Carey et 
al, 2014), and is safe and acceptable to clinicians and patients (Latter et al 2010, Courtenay et al 
2011, Courtenay et al, 2010). Despite the importance of diabetes management, which absorbs 10% 
of NHS expenditure (DoH 2006b), and the significant role that nurses play in this area of care, there 
is no evidence on the value added by nurse prescribers, compared to those without prescribing 
capability.  
 
Background 
In the UK, the number of people diagnosed with diabetes is 2.6 million and by 2025, this figure is 
expected to rise to 4 million (Diabetes UK 2010). Most of these cases will be Type 2 diabetes, Type 1 
accounting for approximately 10% of all cases (Diabetes UK 2010). Since the 1990s, care for people 
with diabetes has been increasingly managed within primary care, with referrals to specialist 
services for unstable or complex patients (DoH, 2003). Primary care teams provide routine care for 
about 75% of diabetic patients and approximately 80% of general practices have a nurse with 
training in diabetes (Audit Commission 2000). One third of diabetes clinics in primary care are run by 
practice nurses (National Audit Office, 2012). These nurses provide individualised care, education 
and promote patient safety, acquisition of physical skills and self-care. Nurse management in 
primary care has been reported to result in improved outcomes, including glycaemia control, blood 
pressure, lipid profiles, and patient satisfaction (Carey & Courtenay, 2007, Cook-Johnson et al 2012).  
 
The use of medicines is an important component of the care of people with diabetes and nurses 
have become increasingly involved in this activity (James et al., 2009). A national survey identified 
that just over 30% of a random sample of 1992 nurse prescribers, over 60% of whom were in general 
practice, prescribed between 1 and 5 items each week for patients with diabetes (Courtenay and 
Carey, 2008b). There is evidence that nurse prescribing enables a more patient-centred and holistic 
approach to care, and an opportunity to increase self- management (Bradley and Nolan 2007).  
Specifically,  nurse prescribing has been associated with  improved access, continuity of care, 
partnership working, information exchange and medicines concordance (Jones et al 2007, Stenner 
and Courtenay 2008, Berry et al 2008, Courtenay et al 2009b).  Through regular contact and good 
communication, prescribing nurses build ongoing relationships with patients that inspire confidence 
and trust and result in improved management (Courtenay et al 2010, Stenner et al 2010).  
 
In parallel with pharmacological management, self-care contributes to successful metabolic control, 
improved quality of life and reduced complications (DoH, 2007,  DoH, 2008, Healthcare Commission, 
2007, Povey & Clark-Carter, 2007, American Diabetes Association, 2014, Odegard & Capoccia, 2007, 
Deakin et al, 2005). Self-care is an ongoing process whereby patients learn to adjust medicinal and 
lifestyle factors in order to manage this complex and progressive condition  
(Paterson & Thorne, 2000). Widespread use of glycosylated haemoglobin as an indicator of 
metabolic control, and use of blood glucose monitoring, has contributed to this shift in responsibility 
of care to the patient. Nurses play an important role in educating and supporting people with 
diabetes so they are prepared to successfully self-manage the condition through healthy diet, 
exercise, medicines adherence and problem solving/coping skills.  
 
THE STUDY 
 
Aims  
The overall aim of the study was to compare the processes, outcomes and costs of care of people 
with diabetes managed in English general practice by nurse prescribers, compared to those of nurses 
without a prescribing capability, in order to inform the decisions of those engaged in service 
organisation and care delivery.  
 
The specific objectives were to compare nurse prescribers and non-prescribers with respect to a) the 
characteristics of the people  with diabetes that they manage, b) activities and processes of care, 
especially around medicines management, c) patient outcomes over a six month period, specifically 
self-management behaviours, clinical indicators, satisfaction, d) resource implications and costs for 
general practice. 
 
Design 
A case study design was used as the overarching framework for a comparative investigation using 
multiple data collection methods in a real life context (Jick, 1979, Yin, 1994).  
 
Participants 
Six general practices in which care for patients with diabetes was provided by a practice nurse with a 
prescribing qualification were matched with six practices in which care for patients with diabetes 
was provided by a practice nurse without a prescribing qualification (12 case study sites in total). 
Sites with prescribing nurses were purposively selected from earlier national survey (Courtenay & 
Carey 2008a) and case study research (Stenner et al 2010) to include different geographical locations 
throughout England, and both rural and urban settings. 
 
Initial telephone contact was made with the nurse prescribers to explain the research. Those 
interested were sent the study protocol so that their involvement could be discussed within the 
general practice, and permission obtained.  Each of the six nurse prescribers recruited were asked to 
identify a ‘matched’ site i.e. a general practice in the same geographical area, with a practice nurse 
with similar specialist training but without prescribing capability, and who had a similar case load of 
patients with diabetes. These nurses were contacted by the research team and recruited following 
the same process as for prescribers. Each nurse was asked to approach 30 consecutive patients (see 
sample size calculations below) attending for either annual or six month diabetes review, and who 
met inclusion criteria including:  
 Have a diagnosis of Type 2 diabetes  
 Taking oral hypoglycaemic medication insulin or a mixture of both for their diabetic 
condition  
 Aged 16 years or over 
 Been a patient of the nurse for at least one year  
 Well enough (mentally and physically) to take part and give informed consent  
 Capable of understanding English language /written or verbal instruction, or have a 
companion willing to help translate/complete questionnaires   
 Most recent HBA1c at or above 6.5% (normal parameters 4%-5.9%), to enable possibility of 
showing improvement over the period of the study.   
 
People with Type 2 diabetes being treated by diet alone (not on any diabetes medication) were 
excluded. 
 
Patients meeting the inclusion criteria were provided with an information sheet by the nurse and, 
with permission, their contact details were passed to the research team. A researcher then 
contacted each volunteer to answer any queries and confirm willingness to participate. Since 
recruitment was slow in five general practices, the medical records of patients with diabetes on the 
case load of each nurse were searched by an administrator to identify those who fulfilled the 
inclusion criteria. To aid recruitment, the requirement that patients had known the nurse for at least 
one year was dropped. Eligible patients were sent a letter via their General Practice inviting them to 
participate in the study and enclosing a return-paid envelope for response to the research team.  
 
Data collection 
In each case study site, mixed methods were used to collect data over a six month period.  Data 
collection took place in all sites simultaneously between November 2011 and December 2012.  Site 
visits and interviews with nurses were conducted to gather information about the practice and their 
backgrounds. Telephone interviews were conducted by researchers with patients at baseline, 3 and 
6 months. Further patient –related information was gathered by nurses from clinic records.  In 
addition, nurses kept diaries of their contacts with each patient over the study period to record care 
given and medicines management activities.  A sample of consultations was observed.  One case 
study site was used to pilot the data collection instruments and no refinements were required. 
Data gathered covered: 
 Patient socio-economic and medical characteristics 
 Patient reported outcomes (self-care and satisfaction) 
 Clinical outcomes (HBA1c and BMI) 
 Nurse activities and processes of care  
 
Within the other data gathering exercises, information was collected on the ways in which use of 
nurse prescribers (rather than non-prescribing nurses) might impact practice resource implications 
and costs, including:  
 The seniority of the nurses (to explore whether nurses with prescribing qualifications were 
generally associated with different professional grades, and hence employment costs) 
 Consultation frequency and duration 
 Demands made by nurses on other GPs or other health professionals for support or 
prescription signing 
 Prescribing frequency 
 Patient use of other health services for diabetes-related issues other than from the diabetes 
nurse (to indicate the comprehensiveness of the nurse care).   
Details of the data collection and instruments are presented in Table 1. Wherever possible, validated 
instruments were used. 
 
Table 1 goes here 
 
Self-care, was selected as the primary outcome because education and support for self-care is an 
important component of care for people with diabetes (DoH, 2003, DoH, 2007, DoH, 2008, 
Healthcare Commission 2007), and the promotion of self-care is a specific area of care in which 
nurses are involved (Carey & Courtenay, 2007). Three satisfaction instruments were used to indicate 
different aspects of quality of care, including information about medicines, general management of 
chronic conditions and convenience of appointment making and waiting. Nurses were asked to 
extract a range of clinical indicators from individual patient records, including HbA1c test results, 
blood pressure, lipid profile, body mass index (BMI), smoking status, microalbumin urea, foot 
examination, and retinal screening. However, it transpired that much of the requested information 
was not available for the required time period for many patients, so only the most frequently 
recorded indicators (HBA1c and BMI) could be analysed.   
 
Ethical considerations 
Ethical approval for the study was obtained from both University and NHS Research Ethics 
Committee (REC) i.e. Surrey REC (Ref: 11/LO/0053). Research and development approval was 
obtained in each Primary Care Trust.  
 
Sample size 
With regard to the primary outcome of self-care management, as measured by the revised SCSDA, 
Lin et al (2006) report a maximum standard deviation of 2.5 amongst the diabetes self-care 
activities. On this basis, in order to detect an underlying mean difference of  2 days in frequency of 
any activity, with size = 5% and power = 80%, using a 2 sided test, a minimum of 26 subjects are 
needed in each nurse prescribing and non- prescribing nurse site. Allowing for a drop out rate of 10% 
with regard to provision of information on such a primary outcome variable, a total of at least 29 
consecutive patients were needed from each site, to enable a statistically sound comparison to be 
made between any specific pair of nurse prescriber and non- prescribing nurse sites at any time 
point during the study. A target recruitment of 30 patients per site was therefore set. 
 
Data Analysis 
Quantitative patient level data were entered onto SPSS version 21, IBM Corporation 2012©. 
Although the intention had been to consider each matched pair or nurses as a unit only two pairs 
approached the target of 30 patients for the prescribing nurse and 30 patients for the non-
prescriber. Hence paired comparisons would not be statistically credible in the remaining four pairs. 
A decision was therefore made to combine data from the six sites at which nurses were able to 
prescribe, and to conduct a global comparison with the combined data from the six sites at which 
nurses did not prescribe. 
 
The characteristics of patients of prescribing and non-prescribing nurses were compared at 
recruitment.  Self-care, HBA1c and BMI outcomes of patients of each type of nurse were compared 
across the six month follow-up period, and satisfaction were compared at the six month end point.  
Activity data recorded in nurse diaries (such as number and duration of consultations, medication 
management activities), and from observations, were analysed descriptively using medians and 
ranges and compared between prescribing and non prescribing sites.  All comparisons were 
conducted using appropriate statistical tests, as indicated on the tables reporting the results.  
 
Economic analysis 
The resource implications of employing nurses with and without a prescribing qualification to 
manage patients with diabetes in general practice were explored from the perspective of the 
National Health Service. Costs were calculated in British pounds.   
 
The costs to practices of employing prescribing and non-prescribing nurses were based on the 
middle of the pay band reported by nurses in the study, using national pay scales (Curtis 2013). 
Where statistically significant differences existed in consultation outcomes with cost implications 
between the two types of nurse (i.e. consultation frequency, duration, advice seeking from GPs and 
other health professionals, obtaining GP signatures on prescriptions, medication reviews and 
changes), the differences in costs were calculated using national unit costs (Curtis 2013).  Patient use 
of health services (other than from the nurse) between recruitment and 3 month follow-up and 
between 3 and 6 month follow-up was summed, by type of service, and frequencies of use were 
compared between patients of nurses with and without prescribing capability. No statistically 
significant differences were found in use of other health services, so cost implications were not 
calculated.  
 
RESULTS 
Characteristics of participants 
Six matched pairs of sites were recruited. Pairs were well matched by geographical location, but 
there were minor variations within pairs in some nurse characteristics.  Apart from sites 1 and 2 
where annual patient reviews were conducted by GPs, and three sites where insulin initiation was by 
GPs, all routine care of people with diabetes was conducted by nurses (including annual and six 
month reviews, medication initiation and changes and telephone advice) (Table 2). Non prescribing 
nurses tended to refer non routine patients to GPs or other services whereas nurse prescribers 
tended to be the key provider for more complex patients.  
 
Table 2 goes here 
 
Data were collected from a total of 214 patients: 131 (61.2%) nurse prescriber sites; 83 (38.8%) in 
non-prescriber sites. There were no statistically significant differences between groups with respect 
to gender, living arrangements, employment status, type of accommodation occupied or educational 
level. The majority of the sample were male and aged between 62 and 64 years, lived with a partner, 
owned their own accommodation, and had one comorbidity. Patients at the non-prescriber sites 
comprised a statistically significant higher proportion of Caucasians. Those at the prescriber sites 
had been diagnosed with diabetes longer, and had been cared for by the nurse longer (Table 3).  
 
Table 3 goes here 
 
Self-care behaviours 
Patient-reported diabetes self-care activities mean scores across recruitment, 3 months and 6 months 
follow ups, were not significantly different between the prescribing and non-prescribing nurse 
groups. Blood glucose testing was found to be more prevalent in the nurse prescriber group (mean 
3.4 days per week over six month period, compared with 2.1 for the non-prescribing nurse patients; 
p=0.001). However the difference is non-significant when considering only patients who reported at 
each assessment point that they were asked by their nurse to test their own blood sugar, which was 
significantly higher in the prescribing nurse group (Supplementary information Table S1). 
 
Satisfaction 
At the end of the six month observation period, the CEP satisfaction summative score, relating to 
aspects of care provided by the diabetes nurse, indicated a significantly higher level of satisfaction 
amongst the patients of prescribing nurses than amongst those of the non-prescribing nurses (mean 
4.83 vs. 4.70; p=0.035). This higher level of satisfaction arose specifically in four items: ‘the nurse 
knows which symptoms have been discussed before’ , ‘the treatment helps to control my diabetes’, 
‘the nurse provides advice that can actually be implemented’, ‘the nurse helps me to cope with 
diabetes’. No statistically significant differences were observed in the SIMS or UOOQHCD measures 
(Supplementary information Table S2). 
 
Clinical indicators  
No statistically significant differences between the nurse prescribing and non-prescribing groups 
were found with regard to the initial and changes in raw scores for HbA1c and BMI (Table 4). 
However, a statistically significant decrease in HbA1c was observed in both groups between 
recruitment and the end of the project (i.e. 6 months later).  Additionally, a statistically significant 
decrease in mean BMI from recruitment to the end of the project was observed in the patients of 
the nurse prescriber (Table 4). 
 
Table 4 goes here 
 
Activities, processes and medicines management 
There was no statistically significant difference in the number of face-to-face or telephone 
consultations over the 6 months between the patients of nurse prescribers (mean 2.67) and non-
prescribing nurses (2.40). However, the face-to-face consultations of nurse prescribers were 
significantly longer than those of nurses without prescribing capability (median 27.7 vs. 20.0 minutes) 
(Table 5). 
 Table 5 goes here 
 
Compared to nurse prescribers, the non-prescribing nurses recorded significantly more times when 
they: discussed the patient's medication with doctor or colleague and made a recommendation via 
letter/email or phone call to GP for medicine(s) to be prescribed (34/329, 10.3% vs. 60/199, 30.1%); 
issued a prescription for GP to sign immediately following/during the consultation, or later (0 vs. 
42/199, 21.1%).There were no further statistically significant differences with regards to the other 
medicines-related activities listed on the diary template, or in giving patients information about 
medicines, although there was some indication that medication stopping and starting tended to be 
higher for the patients of nurse prescribers (Table 5). Analysis of the data from observation revealed 
no significant difference in the tasks undertaken by the two types of nurses, other than in 
prescribing of medications (Figure 1). 
 
Figure 1 goes here 
 
Resource implications and costs 
Employment costs of nurses: Generally the prescribing nurses in the study were employed on higher 
bands than nurses without prescribing capability. Of the six prescribers (Table 2), three were band 8 
(salary range £45,022 to £90,753), two band 7 (median salary £38.057), and one band 6 (median 
£31,752). Those without prescribing capability included three band 7, one band 6 and two unknown. 
The oncosts to practices of employing nurses would inflate salaries by approximately 25%. Assuming 
practice overheads are similar for each nursing grade, hiring a more senior nurse with prescribing 
qualifications could thus add some £8,000 per annum to the practice budget (band 6 vs. band 7, 
depending on the point on the scale) or more if an experienced band 8 nurse is employed. Whilst 
half of the prescribing nurses were band 8, most non prescribers (where band was known) were 
band 7.  
 
Consultation costs: There were no differences in the frequency of consultations by patients managed 
by the different types of nurse, but the 7.7 minute average longer face-to-face consultation time of 
nurse prescribers, compared to non-prescribing nurses, comes at a cost of approximately £6.00 
based on patient contact costs for band 7 nurses, without overheads (Curtis 2013), and would be 
greater for band 8 nurses.  
 
Advice seeking from other professionals and GP prescription signing: No data were collected on 
whether nurses who needed to consult with GPs or other professionals about patients, or get GPs to 
sign prescriptions, undertook these tasks within the recorded consultation time, or additionally. 
Similarly the time expended by GPs or other colleagues on these tasks was not recorded. Following 
discussion amongst the researchers who had collected information from nurses, it was assumed that 
advice seeking (verbal face-to-face or phone, email or other written communication) about patients 
were dealt with by GPs in 5 minutes for each enquiry, and that each prescription signed by a GPs 
took 2 minutes of their time. Applying the national rate (Curtis 2013) for 1 minute of GP patient 
contact time (£3.80), the cost of a GP providing advice to a non-prescribing nurse was thus £19 and 
signing a prescription was £7.60. 
 
Non-prescribing nurses seek support from GPs in 20 more consultations in every 100 (10.3% vs, 
30.1%, Table 5), which, at £19 for the estimated 5 minutes of GP time equates to £380 per 100 
consultations.  Similarly, they ask GPs to sign 20 prescriptions in every 100 consultations (Table 5), 
which, at £7.60 for an estimated 2 minutes of GP time equates to £160 per 100 consultations.  The 
longer consultations of nurse prescribers, however, is £600 for 100 consultations, and exceeds the 
total additional GP time incurred by non- prescribing nurses by £60 (£0.60 per consultation).   
 
Prescribing costs: There was no statistically significant difference in new prescribing between the 
two types of nurses. The trend for nurse prescribers to stop or amend medications was not costed.  
 
Utilisation of other health services: No significant differences were found between the patients of 
prescribing and non-prescribing nurses in their utilisation of any other health services 
(Supplementary information Table S3).  
 
Summary of cost differences: On both the fixed costs of employing prescribing nurses, and the 
variable costs associated with their consultations, nurse prescribers appear to be more costly to 
general practices. If the apparent tendency for nurse prescribers to engage in more medication 
changes and new prescribing is also considered, this would add to the differential.  Use of other 
health services by patients or prescribing and non-prescribing nurses did not differ.  (Full summary of 
cost differences, see Supplementary information Table S4). 
 
DISCUSSION  
There was a higher proportion of Caucasian patients amongst those treated by the non-prescribing 
nurses. Otherwise the demographic characteristics of the patients with diabetes managed by 
prescribing nurses and non-prescribing nurses were similar, and they had an equivalent number of 
diabetes-related comorbidities.  The patients of prescribing nurses had been diagnosed longer and 
been with the nurse longer than the patients of non-prescribing nurses, and the reason for this is not 
known, but may reflect staff turnover in the practices. The analysis of outcomes shows that patients 
are more satisfied with consultations with prescribing nurses (including nurses knowledge of what 
symptoms had been discussed previously, and the extra information and advice they received), and 
this may reflect the longer term relationship prescribers had with their patients, and the longer than 
average length of consultations of prescribing nurses.  However, the analysis did not suggest that 
this extra attention resulted in better HBA1c, or self-management behaviours amongst the patients 
of nurse prescribers, and no differences were observed in utilisation of other services between the 
patients of the two types of nurses.   
 
The nurse prescribers in this study were mostly higher band than the non-prescribing nurses and this 
increases the salary cost to practices. Furthermore, prescribing nurses incurred extra costs due to 
their longer patient consultations (by an average of 7.7 minutes), that would manifest in the practice 
as reduced patient throughput.  We do not know why prescribing nurses had longer consultations 
but this possibly reflects practice policy on the duration of appointment slots, and the expectation 
that prescribing nurses would engage in more activities and information exchange with patients.  
Non prescribing nurses incurred costs of GP time by seeking advice from them more frequently than 
prescribing nurses , and also for getting prescriptions signed, but the cost of this did not offset the 
higher salary and reduced patient throughput of prescribing nurses. Cost differences between the 
two groups of nurses are sensitive to the band of nurse employed, and point within the band; the 
difference to GP practice costs is likely to be minimal if a nurse with prescribing capability can be 
hired on the same band as those without, but this would imply no return for nurses from investing in 
the additional qualification. 
 
Self-care was reported as high across the whole patient sample. In-line with other work, patients 
reported the highest levels of self-care for medicine taking, and greater dietary than exercise self-
care (Toobert et al 2000). However, blood glucose testing was low, in contrast to Toobert et al 
(2000), who reported the highest levels of self-care for in this activity. Although it is advocated that 
access to equipment for self-monitoring of blood glucose for people on medicines such as metformin 
should be based on an individual assessment, it is evident that in the UK, a number of primary care 
organizations have policies which restrict the provision of blood glucose test strips (Diabetes UK, 
2013), which may account for these lower levels.  Nurse prescribers were more likely to recommend 
blood glucose testing to their patients, and this activity was more prevalent in this group than 
amongst the patients of non-prescribing nurses. An inclusion criteria for the study was that patients 
were recruited with mildly elevated HBA1c, and during the 6 month study period, there was a 
significant decrease in HbA1c across patients of both prescribing and non- prescribing nurses. BMI 
was also significantly decreased in patients of prescribers. These trends indicate, in line with other 
evidence, that nurse-led care benefits patient health (Cook-Johnson, 2012).  
 
In-line with systematic reviews of nurse and doctor-led care, (Laurent et al, 2008, Horrocks et al, 
2002), patients of both types of nurse reported high levels of satisfaction, including regarding 
information on medicines. 
Nurse’s knowledge of symptoms discussed previously, confidence in treatment, the provision of 
implementable advice, and support to cope with the disease, were aspects of care rated more highly 
by patients of nurse prescribers.  Support to cope with chronic illness has been rated more highly 
within nurse led care (compared to doctor-led) in other studies, and attributed to longer time nurses 
spend in consultations which enables more health information to be provided (Laurant et al 2004).  
Greater information exchange due to longer consultations may also explain the higher levels of 
satisfaction amongst patients of nurse prescribers in our study. Furthermore, the longer 
relationships nurse prescribers had with patients may have meant better continuity of care.  Since 
satisfied patients are more likely to cooperate with treatment, to maintain a continuing relationship 
with a practitioner, and enjoy better health outcomes (Gasquet et al, 2004), the impact of nurse 
prescribers on satisfaction is important.  
 
Limitations  
The case study design renders the findings context specific. Moreover, outcomes such as satisfaction 
may be affected by the personal characteristics of individual nurses.  Patient recruitment problems 
encountered meant that the planned comparisons between matched pairs had to be abandoned. 
Resource limitations meant that nurses, rather than an independent researcher, recorded data in 
the diaries, and guidelines may not have been followed.  Inconsistencies were observed for the 
recording of some tests meaning information items could not be analysed. Other limitations include 
reliance on patient self-report of some outcomes and recall for service use information. Also the 
follow-up period was only six months, so longer term trends could not be identified.  Six months is a 
limited time to establish changes in behaviour and key outcomes in the context of the long period 
over which most of these patients had already been managed. 
 
Consultation times were self-reported by nurses and not validated but, we have no reason to 
assume inaccurate estimation differed between groups. Other uncertainties in the costing study 
relate to the GP time taken outside nurse consultations to provide advice or write prescriptions for 
non-prescribing nurses.  Since no statistically significant difference in medicine management tasks 
was found, the costs of prescribing were not calculated although the data suggested a slight trend 
for nurse prescribers to engage in more medicine changes and new prescribing than non-prescribing 
nurses. Moreover, the study focussed on provider costs and did not consider costs to patients, such 
as the possible need to return to the practice to collect prescriptions that non-prescribing nurses had 
to ask GPs to sign after the consultation. While no differences between the groups were identified 
using the work sampling method, observer field notes indicated that prescribing nurses spent more 
time discussing medicines management than non-prescribing nurses who focused more on routine 
testing and general lifestyle advice. It is possible that a more refined tool that is specifically designed 
to measure differences relating to medicines management may produce more accurate results.  
 
The costs calculated in the study concentrated on care provided by nurses for patients with diabetes, 
but practice nurses see patients with a range of conditions, and people with diabetes are only one 
group of patients with whom they consult and prescribe medicines. Few practices in the UK are likely 
to have sufficient patients with diabetes to warrant employing one diabetes nurse on a full time 
basis, although part time or shared arrangements do exist. One practice in this study had a visiting 
specialist diabetes nurse, but the disadvantage of this arrangement is that nursing cover for diabetes 
patients is not available at all times. To develop an overall picture of the outcomes, costs, and 
benefits of hiring a general practice nurse prescriber, information on patient and clinical outcomes 
would need to be collected across the whole spectrum of their work.   
 
CONCLUSION  
The finding that the diabetes management activities of nurses with and without prescribing 
capability are similar is perhaps not surprising since much care for people with chronic conditions in 
general practice in England is driven by the Quality and Outcomes Framework (Health and Social 
Care Information Centre 2013). This rewards practices for delivery to pre-specified targets, with an 
overall aim of improving quality of care and outcomes, and reducing differences in the patient 
experience.  From nurses’ perspectives, holding an independent prescribing qualification seems to 
enhance career prospects, and may add to job satisfaction, but budget conscious GP practices may 
question the rationale of investing in a more expensive resource when a nurse commanding a lower 
salary can produce similar outcomes for QOF.  Care for people with diabetes has become 
increasingly managed in primary care by nurses, possibly reflecting the higher cost of hiring a GP. 
However, there is a need for careful planning of task shifting according to competencies. Further 
research on the deployment of nurses with prescribing capabilities is required, including around 
their wider use in general practice, and their impact on the patient experience. 
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 Table 1. Summary of data collection arrangements and instruments 
 
Category of 
data 
Method of 
collection 
Timing of 
collection 
Items and instruments 
Characteristics 
of practices 
and sites 
Site visit, 
interview 
with nurses,  
Before 
baseline 
data 
collection 
from 
patients 
Practice – Location, setting, number of GPs 
 
Nurses- Age, highest education qualification, salary band, full/ part time status, years 
with practice, years with prescribing qualification (or none), diabetes training, years 
of experience in diabetes care, whether initiate insulin treatment, whether treat 
other long term conditions 
Characteristics 
of patients  
Telephone 
interview 
with patient  
Baseline  Socio economic - living arrangements i.e. alone /with others, type of accommodation, 
employment status, education, ethnicity 
Clinical 
records by 
nurse 
Baseline  Clinical - date of birth, sex, when the patient was diagnosed with diabetes, diabetes 
related co-morbidities, length of time managed by nurse 
Patient 
reported 
outcomes 
Telephone 
interview 
with patient  
Baseline,  
3 months, 
 6 months 
Self-care (primary outcome) was measured by the widely used Revised Summary of 
Diabetes Self-Care Activities (revised SDSCA) (Toolbert et al, 2000, Shrivastava et al 
2013).   
 
The 11 items ask: the number of days during the previous seven that they have 
followed dietary (4 items) and exercise (2 items) guidelines, tested their blood sugar 
(2 items), undertaken foot care (2 items), and the number of cigarettes smoked each 
day (1 item). Variables were combined to derive Diet-General, Diet-Specific, Exercise, 
Foot Care and Smoking, and calculated for each patient as a mean score across 
recruitment, 3 months and 6 months.    
 
Additional items were added on taking medications to schedule, and whether their 
nurse recommended routine blood sugar testing.  
Telephone 
interview 
with patient  
6 months 3 measures of satisfaction: 
- The 17 item Satisfaction with Information about Medicines Scale (SIMS) (Horne et 
al, 2001). Two summary indicators are calculated for ‘action and usage’ (items 1 to 
9) and ‘potential problems’ (items 10 to 17), range 0 (none/ too little) to 100 
(about right).  
- The 14 item Chronically ill patients Evaluate general Practice (CEP) questionnaire 
(validated for doctor-led care by Wensing et al 1998, and nurse-led care by Laurant 
et al 2008) comprises a global satisfaction measure (item 1), and 13 statements 
reflecting communication skills, knowledge and treatment, each scored 1 (poor) to 
5 (excellent). A summary score was derived from the mean of items 2-12. 
(Questions 13 and 14 were excluded as not relevant.)  
- Appointment making and waiting time dimensions (7 items) of the Unidimensional 
Outpatients' Opinion of Quality of Hospital Consultation Departments (UOOQHCD) 
(Gasquet et al., 2004), with wording adapted to relate to nurses, covered ease of 
making appointments, speed of access, and waiting time. Scoring is on a scale 1 
(worst) to 5 (best) and an overall mean was computed. 
 
Clinical 
indicators 
Clinical 
records by 
nurse 
Baseline, 
6 months 
HBA1c, in mmol/mol (indicator of glycaemic control) 
Body Mass Index 
Nurse 
activities and 
processes of 
care 
Individual 
diary nurse 
completed 
for each 
patient 
Over six 
month 
period that 
patients 
were in the 
study 
Following each patient contact, nurses indicated, from a list in a diary template 
(developed by the researchers in previous work (Courtenay et al., 2012), those 
activities in which they had been involved, including: whether the consultation was a 
face-to-face or by telephone; if, following a review of the patient’s medicines, 
decisions to recommend, amend, stop, or prescribe medicines for patients were 
made; whether certain actions had been taken (such provision of advice, discussion 
of medication with a doctor/ other health professional, doctor asked to sign 
prescription, a recommendation for over-the-counter medicines).  
Nurses were also asked to estimate (in minutes) the duration of each consultation.  
Observations 
of nurse 
consultations  
2 x 2 hour 
observation 
periods at 
each site 
Structured observations of consultations using the work sampling instrument 
developed by Gardner et al. (2010). Observations of nurse activities were conducted 
at 5 minute intervals in 2 x 2 hour blocks randomly assigned during clinic times when 
nurses were scheduled to see patients with diabetes. A trained researcher identified 
and categorised the main activity being undertaken by the nurse at each observation 
point (direct patient care (physical assessment, history taking, information exchange), 
indirect care (documenting patient notes, discussion with colleague, data retrieval), 
service related (including research, professional development, meetings).  
Resource 
implications 
and costs 
Interviews 
with nurses 
Baseline Grade / banding of each of the nurses in the study. Bands range from 5/E to 8/I, with 
higher bands reflecting greater clinical expertise and managerial responsibility, and 
attracting higher salaries.  
Individual 
diary nurse 
completed 
for each 
patient 
Over six 
month 
period that 
patients 
were in the 
study 
5 items related to consultations with individual patients, were also examined for 
differences between the two types of nurse:  
- number consultations;  
- duration of consultations; 
-  frequency with which nurses sought advice from a GP or other professionals 
regarding patients’ medications;  
- frequency with which nurses asked GPs to sign  prescriptions;  
- frequency of medication reviews, changes and new prescribing.   
Telephone 
interview 
with patient  
3 months, 
6 months 
Self--report use of health services for diabetes –related issues (other than those 
involving their diabetes nurse) in the previous 3 months including: visits to the GP 
surgery, phone calls to the GP and diabetes nurse specialist, visits to other nurses and 
health professionals and hospital outpatient clinics, Accident & Emergency visits, 
hospital admissions and number of inpatient days.  
 
 
Table 2. Characteristics of the sites and nurses 
 
 
Pair Case 
study 
site 
Number 
of 
patients 
recruited 
Type  
of 
nurse 
Number 
of GPs 
In 
practice 
Setting Location 
in 
England 
Nurse 
age in  
years 
Salary 
Band 
Full or 
part 
time 
Education 
highest 
Specialist 
diabetes 
training 
Insulin 
initated 
by 
nurse 
Years at 
GP 
practice 
Years of 
experience 
in diabetes 
care 
Years with 
prescribing 
qualification 
Treat 
other long 
term 
conditions 
1 1 12 NP 9 Urban Midlands 57 8 FT Degree Yes Yes 8 8 4 Yes 
2 4 NNP 9 Urban Midlands 41 7 PT 34% RGN Yes Yes 12 5 - Yes 
2 3 20 NP 1 Urban Midlands 55 7 PT 26% RGN Yes Yes 12 16 10 Yes 
4 8 NNP 1 Urban Midlands 53 6 PT 26% RGN No No 10 10 - Yes 
3 6 30 NP 4 Urban Middlesex 52 7 PT 30% Degree Yes Yes 14 10 N/A Yes 
5 26 NNP 4 Urban Middlesex 49 N/A PT 21% RGN Yes Yes 11 14 - Yes 
4 7 30 NP 5 Rural Yorkshire 38 8 FT Diploma Yes Yes 4 4 8 Yes 
8 7 NNP 6 Urban Yorkshire N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
5 9 31 NP 8 Rural Yorkshire 55 6 PT 30% Degree Yes Yes 25 32 7 No 
10 30 NNP 9 Rural Yorkshire 52 7 PT 30% Masters Yes Yes 17 10 - Yes 
6 11 8 NP 7 Urban London 45 8 PT 30% Masters Yes No 15 15 4 Yes 
12 8 NNP 4 Urban London 32 7 PT 30% Degree Yes No 4 4 - Yes 
 
Key: NP, Nurse Prescriber; NNP, Not a Nurse Prescriber;  N/A data not available
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Table 3. Background characteristics of patients*, comparison between service groups   
 
Characteristic 
Nurse Prescriber  Non Prescribing Nurse Chi-
square 
value 
Frequency Percentage Frequency Percentage 
Sex: Male 87 66.4 45 54.2 .074 
Living Arrangements: 
Live alone 24 18.3 18 21.7 
.951 
Live with children 
(without partner) 
4 3.1 3 3.6 
Live with partner (with 
children) 
35 26.7 22 26.5 
Live with partner 
(without children) 
61 46.6 37 44.6 
Live with other relatives 6 4.6 3 3.6 
Live with others 1 .8 0 0 
In Paid Employment: Yes 47 35.9 34 41 .455 
Type of 
Accommodation: 
Owner-occupied 89 67.9 62 74.7 
.120 
Privately rented  12 9.2 11 13.3 
Rented from local 
authority/ housing 
association 
25 19.1 10 12 
Other  5 3.8 0 0 
University education: Yes 25 19.1 13 15.7 .523 
White / Caucasian 
ethnicity: 
Yes 119 90.8 82 98.8 .018 
 N Mean (SD) N Mean (SD) Unpaired 
t-test p-
value 
Age in years (at first interview) 131 64.22 
(11.32) 
83 61.99 
(11.50) 
0.164 
Number of years (at recruitment) since diagnosis 
of diabetes 
128 9.09  
(5.91) 
83 6.24 
(5.75) 
0.001 
How long patient has been treated by nurse 127 5.23 
(5.40) 
74 3.11 
(3.86) 
0.001 
Number of diabetes-related co-morbidities 129 1.12 (0.78) 83 1.24 (0.74) 0.279 
 
*Data were collected from a total of 214 patients: 131 (61.2%) nurse prescriber sites; 83 (38.8%) in 
non-prescriber sites. There were 194 patients who supplied information at both 3 and 6 month 
follow-up, three with data at neither point, 16 with data at 3 months but not at 6 months of which 
1 had died and was excluded, 1 with data at 6 months but not at 3 months.  Where data were 
provided at one but not both follow up points, the available data were averaged to provide a value 
over the whole 6 month period.  
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Table 4. Clinical indicators: Comparison between service groups 
 
Test result 
Nurse Prescriber 
Non Prescribing 
Nurse 
Unpaired  
t-test: 
p-value N Mean (SD) N Mean (SD) 
HbA1c at recruitment to study (mmol/mol) 128 63.0 (12.6) 83 63.6 (14.4) 0.770 
HbA1c change ( end of project  -   at recruitment) 
(mmol/mol) 
115 
-2.1 (10.9) 
Paired t-test: 
p=0.043 
72 
-4.6 (13.0) 
Paired t-test: 
p=0.004 
0.152 
BMI at recruitment to study 115 33.0 (9.1) 79 32.7 (6.0) 0.814 
BMI change ( end of project  -  at recruitment) 67 
-0.44 (1.45) 
Paired t-test: 
p=0.015 
62 
-0.06 (1.37) 
Paired t-test: 
p=0.730 
0.130 
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Table 5. Patient contact and medicines management activities of prescribing and non prescribing nurses 
 
 
 Nurse Prescriber Non Prescribing nurse Mann-
Whitney  
U test:  
p-value 
N Median Range N Median Range 
Number of face-to-face consultations 123 2 0 to 9 83 2 1 to 6 0.502 
Number of telephone consultations 123 0 0 to 11 83 0 0 to 5 0.650 
Duration of face-to-face consultation 
(minutes) 
121 27.67 10 to 45 80 20 10 to 
40 
<0.0005 
Duration of telephone consultation (minutes) 35 6.25 2 to 40 19 5 5 to 15 0.478 
Number of times patient's medication was 
reviewed 
123 2 0 to 11 83 2 0 to 5 0.829 
Number of times a change to patient's 
medication was required 
123 1 0 to 6 83 1 0 to 5 0.254 
Number of times existing medications had to 
be stopped or amended 
123 1 0 to 6 83 0 0 to 4 0.089 
Number of times new medication was 
required 
123 0 0 to 4 83 0 0 to 2 0.144 
Number of times advice was given to patient 
about medicine 
123 1 0 to 9 83 1 0 to 4 0.987 
Number of times a patient was 
recommended to buy an over-the-counter 
medicine 
123 0 0 to 1 83 0 0 to 1 0.779 
Number of times medicines were supplied or 
administered via PGD 
123 0 0 to 1 83 0 0 0.153 
  Total Mean  Total Mean T test 
Total consultations (face-to-face and phone) 123 329 2.67 83 199 2.40 0.485 
   %   % Chi Sq 
Number of times  patient’s medication 
discussed with doctor or colleague  
123 33 
 
10.0 83 48 
 
24.1 <.0005 
Number of times GP contacted verbally or 
written about medications to be prescribed 
123 1 0.3 83 12 6.0 <.0005 
Number of time prescription issued for GP to 
sign immediately / during consultation 
123 0  83 35 17.6 <.0005 
Number of times prescription issued for GP to 
sign later 
123 0  83 7 3.5 <.0005 
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Figure 1.  Mean number of times (in 5 minute windows during 2 x 2 hour observation) each CATEGORY 
of work activity seen as predominant, broken down by Nurse Prescriber or Non-Prescribing Nurse) 
 
 
 
 
